UCB USA
在场
UCB USA 的所有者是 UCB.
是其中之一......
UCB 是一家在股票代码 UCB (BE) 下上市的公司。
UCB 在 10 个国家有直接业务。UCB 拥有 10家子公司，其中包括 UCB Australia、UCB Canada 和 UCB France。
他们在：
高管
查看带有其 13 名主要高管的组织结构图
UCB USA 搜索最多的简介
- Taco Van Tiel, Managing Director
- Kimberly Moran, Head, Rare Disease
- Brandon Drew, Global Head of Developed Brands
创建提醒
跟踪 UCB USA 的高管变动
药店
UCB 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
UCB USA 的最新新闻稿
- UCB U.S. News | UCBBack ButtonSearch IconFilter Icon
- A Bright Future: Prioritizing Early Diagnosis, Maintenance, and Remissions in Rheumatology | UCBBack ButtonSearch IconFilter Icon
- New BIMZELX® (bimekizumab-bkzx) Data at ACR Convergence 2024 Highlights UCB’s Efforts to Deliver Differentiated Care for Patients with Psoriatic Arthritis and Axial Spondyloarthritis | UCBBack ButtonSearch IconFilter Icon
- UCB announces U.S. launch of UCB Myasthenia Gravis Scholarship™ for people impacted by myasthenia gravis in the U.S. | UCB
- UCB Receives U.S. FDA Approval for 320 mg Single-Injection Device Presentations of BIMZELX® (bimekizumab-bkzx) | UCB
- Powering the dreams of people impacted by myasthenia gravis (MG) | UCB
- UCB U.S. News | UCB
- UCB showcases new data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session | UCB
- UCB Announces Late-Breaking Two-Year Data for BIMZELX® (bimekizumab-bkzx) in Moderate-to-Severe Hidradenitis Suppurativa at EADV 2024 | UCB
- UCB U.S. News | UCB
- View more press releases Close
通过电子邮件
